Is this you? Create Your Porfile
Avatar

Tadeusz Robak

Military Medical Academy

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Tadeusz Robak is active.

Explore More

Publication

Featured researches published by Tadeusz Robak.

Blood | 2005

HuMax-CD20, a novel fully human anti-CD20 monoclonal antibody: Results of a phase I/II trial in relapsed or refractory follicular non-Hodgkins's lymphoma.

Anton Hagenbeek; Torben Plesner; Peter Johnson; Lars Møller Pedersen; Jan Walewski; Andrzej Hellmann; Brian K. Link; Tadeusz Robak; M Wojtukiewicz; Michael Pfreundschuh; Michael Kneba; Andreas Engert; Pieter Sonneveld; Jørgen Petersen; John Radford

Blood | 2006

Significant Correlation between Survival Endpoints and Exposure to Ofatumumab (HuMax-CD20) in Chronic Lymphocytic Leukemia.

Bertrand Coiffier; H. Tilly; Lars Møller Pedersen; T. Plesner; Henrik Frederiksen; M. H. J. Van Oers; James E. Wooldridge; Janusz Kloczko; Jerzy Holowiecki; Andrzej Hellmann; Jan Walewski; Mimi Flensburg; Jørgen Petersen; Tadeusz Robak

Blood | 2005

HuMax CD20 Fully Human Monoclonal Antibody in Chronic Lymphocytic Leuchemia. Early Results from an Ongoing Phase I/II Clinical Trial.

Bertrand Coiffier; H. Tilly; Lars Møller Pedersen; T. Plesner; Henrik Frederiksen; M. H. J. Van Oers; James E. Wooldridge; Janusz Kloczko; Jerzy Holowiecki; Andrzej Hellmann; J. J. Walewski; Mimi Flensburg; Jørgen Petersen; Tadeusz Robak

Archive | 2013

monoclonal antibody in relapsed or refractory follicular lymphoma: First clinical use of ofatumumab, a novel fully human anti-CD20

Andreas Engert; Pieter Sonneveld; Mimi Flensburg; Jørgen Petersen; Nedjad Losic; Tadeusz Robak; Michael Pfreundschuh; Michael Anton Hagenbeek; Ole Gadeberg; Peter M Johnson; Lars Møller Pedersen; Jan Walewski

Archive | 2010

outcome polymorphisms are independent predictors of non-Hodgkin lymphoma Human leukocyte antigens class II and tumor necrosis factor genetic

Krzysztof Warzocha; Tadeusz Robak; Marek L. Kowalski; Ewa Lech-Marańda; Lucile Baseggio; Bertrand Coiffier; Gilles Salles; Przemyslaw Juszczynski; Ewa Kalinka; Jacques Bienvenu; Grzegorz Woszczek; Maciej Borowiec

Archive | 2010

Leczenie pierwotnych chłoniaków skóry. Rekomendacje Sekcji Chłoniaków Skóry Polskiej Grupy Badawczej Chłoniaków (PLRG) The treatment of primary cutaneous lymphoma. Recommendations of the Polish Lymphoma Research Group (PLRG)

Ewa Lech-Marańda; Waldemar Placek; Janusz Meder; Jan Maciej Zaucha; Jan Walewski; Jadwiga Roszkiewicz; Tadeusz Robak; Krzysztof Leśniewski-Kmak

Archive | 2008

leukemia after failure of first-line imatinib: a randomized phase 2 trial Dasatinib or high-dose imatinib for chronic-phase chronic myeloid

Neil Shah; Andrey Zaritsky; Anatoly Golenkov; Jerald P. Radich; Timothy P. Hughes; Tadeusz Robak; Nina Khoroshko; Tamas Masszi; Aleksander B. Skotnicki; Andrzej Hagop Kantarjian; Ricardo Pasquini; Nelson Hamerschlak; Philippe Rousselot; Jerzy Holowiecki

Blood | 2008

Palifermin Does Not Influence the Incidence and Severity of GvHD Nor Long-Term Survival of Patients with Hematological Diseases Undergoing HSCT

Barbara Nasiłowska-Adamska; Agnieszka Tomaszewska; Richard M. Szydlo; Piotr Rzepecki; Anna Czyz; Joanna Manko; Miroslaw Markiewicz; Tigran Torosian; Maria Bieniaszewska; Beata Piatkowska-Jakubas; Agnieszka Wierzbowska; Dorota Duda; Andrzej Szczepiński; Andrzej Lange; Tadeusz Robak; Aleksander Skotnicki; Andrzej Hellman; Wieslaw W. Jedrzejczak; Jerzy Holowiecki; Anna Dmoszynska; Mieczyslaw Komarnicki; Krzysztof Warzocha; Bożena Mariańska

Postępy Nauk Medycznych | 2007

Epidemiology of acute leukemia in adults in Poland in 2004-2006

Ilona Seferynska; Ewa Orłowska; Anna Ejduk; Stanisław Maj; Jerzy Holowiecki; Slawomira Kyrcz-Krzemien; Tadeusz Robak; Kazimierz Sulek; Monika Paluszewska; Wiesław Wiktor Jędrzejczak; Aleksander B. Skotnicki; Anna Dmoszynska; Andrzej Hellmann; Janusz Kloczko; Lech Konopka; Mieczysław Komarnicki; Barbara Zdziarska; Maria Nowakowska-Domagala; Andrzej Zdunczyk; Andrzej Lange; Grażyna Gadomska; Jolanta Starzak-Gwóźdź; Malgorzata Calbecka; Krystyna Zawilska

Blood | 2005

HuMax-CD20, a novel fully human anti-CD20 monoclonal antibody

Anton Hagenbeek; Torben Plesner; Peter Johnson; Lars Møller Pedersen; Jan Walewski; Andrzej Hellmann; Brian K. Link; Tadeusz Robak; M Wojtukiewicz; Michael Pfreundschuh; Michael Kneba; Andreas Engert; Pieter Sonneveld; Jørgen Petersen; John Radford

Explore More

Collaboration

Dive into the Tadeusz Robak's collaboration.

Top Co-Authors
Avatar

Jan Walewski

Curie Institute

View shared research outputs
Top Co-Authors
Avatar

Jørgen Petersen

Genmab

View shared research outputs
Top Co-Authors
Avatar

Lars Møller Pedersen

Odense University Hospital

View shared research outputs
Top Co-Authors
Avatar

Jerzy Holowiecki

Curie Institute

View shared research outputs
Top Co-Authors
Avatar

Andrzej Hellmann

Medical University of Łódź

View shared research outputs
Top Co-Authors
Avatar

Mimi Flensburg

Genmab

View shared research outputs
Top Co-Authors
Avatar

Pieter Sonneveld

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors
Avatar

Ewa Lech-Marańda

Medical University of Łódź

View shared research outputs
Top Co-Authors
Avatar

Janusz Kloczko

Medical University of Białystok

View shared research outputs
Top Co-Authors
Avatar

Michael Pfreundschuh

Saarland University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge